BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23881516)

  • 21. The anti mullerian hormone- a novel marker for assessing the ovarian reserve in women with regular menstrual cycles.
    Kalaiselvi VS; P S; K P; Krishna G P
    J Clin Diagn Res; 2012 Dec; 6(10):1636-9. PubMed ID: 23373017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
    van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
    Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
    Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
    Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy after cancer: results from a prospective cohort study of cancer survivors.
    Dillon KE; Sammel MD; Ginsberg JP; Lechtenberg L; Prewitt M; Gracia CR
    Pediatr Blood Cancer; 2013 Dec; 60(12):2001-6. PubMed ID: 24038829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.
    Lutchman Singh K; Davies M; Chatterjee R
    Hum Reprod Update; 2005; 11(1):69-89. PubMed ID: 15569700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Anti-Mullerian Hormone, Follicle-Stimulating Hormone, and Inhibin B with Risk of Ovarian Cancer in the Janus Serum Bank.
    Irvin SR; Weiderpass E; Stanczyk FZ; Brinton LA; Trabert B; Langseth H; Wentzensen N
    Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):636-642. PubMed ID: 31932414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
    Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ovarian antral follicle subclasses and anti-mullerian hormone during normal reproductive aging.
    Bentzen JG; Forman JL; Johannsen TH; Pinborg A; Larsen EC; Andersen AN
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1602-11. PubMed ID: 23463653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pituitary desensitization on the early growing follicular cohort estimated using anti-Mullerian hormone.
    Jayaprakasan K; Campbell BK; Hopkisson JF; Clewes JS; Johnson IR; Raine-Fenning NJ
    Hum Reprod; 2008 Nov; 23(11):2577-83. PubMed ID: 18658161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation.
    Yong PY; Baird DT; Thong KJ; McNeilly AS; Anderson RA
    Hum Reprod; 2003 Jan; 18(1):35-44. PubMed ID: 12525438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J; Banah M; McCloud P; Hee J; Burger H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ovarian function markers in users of hormonal contraceptives during the hormone-free interval and subsequent natural early follicular phases.
    van den Berg MH; van Dulmen-den Broeder E; Overbeek A; Twisk JW; Schats R; van Leeuwen FE; Kaspers GJ; Lambalk CB
    Hum Reprod; 2010 Jun; 25(6):1520-7. PubMed ID: 20348556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diminished ovarian reserve in female childhood cancer survivors with regular menstrual cycles and basal FSH <10 IU/l.
    Larsen EC; Müller J; Rechnitzer C; Schmiegelow K; Andersen AN
    Hum Reprod; 2003 Feb; 18(2):417-22. PubMed ID: 12571182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced ovarian reserve in patients with adult polymyositis.
    de Souza FH; da Silva CA; Yamakami LY; dos Santos Trindade Viana V; Bonfá E; Shinjo SK
    Clin Rheumatol; 2015 Oct; 34(10):1795-9. PubMed ID: 26345632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective analysis of ovarian reserve markers as determinant in response to controlled ovarian stimulation in women undergoing IVF cycles in low resource setting in India.
    Singh N; Bahadur A; Malhotra N; Kalaivani M; Mittal S
    Arch Gynecol Obstet; 2013 Sep; 288(3):697-703. PubMed ID: 23529683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
    Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
    Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of ovarian reserve in adult patients with dermatomyositis.
    de Souza FH; Shinjo SK; Yamakami LY; Viana VS; Baracat EC; Bonfá E; Silva CA
    Clin Exp Rheumatol; 2015; 33(1):44-9. PubMed ID: 25571898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.